Skip to main content
. 2017 May 4;8(39):64853–64866. doi: 10.18632/oncotarget.17614

Figure 5. CB2 agonist attenuates H2O2/SD-induced AD-MSCs injury and apoptosis.

Figure 5

A. LDH release in AD-MSCs after respective treatment. B. in vitro BLI for AD-MSCs viability. C. Quantitative analysis of B., n = 3. C. Representative photographs of TUNEL-stained AD-MSCs indicating cell apoptosis. D. Quantitative analysis of C., n = 6. E. Casepase3 activity in AD-MSCs, n = 6. *P < 0.05 between indicated groups.